APYX
Price
$2.16
Change
-$0.12 (-5.26%)
Updated
Jul 10 closing price
Capitalization
47.46M
27 days until earnings call
INMD
Price
$15.18
Change
-$0.05 (-0.33%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
1.82B
14 days until earnings call
Interact to see
Advertisement

APYX vs INMD

Header iconAPYX vs INMD Comparison
Open Charts APYX vs INMDBanner chart's image
Apyx Medical
Price$2.16
Change-$0.12 (-5.26%)
Volume$234.7K
Capitalization47.46M
InMode
Price$15.18
Change-$0.05 (-0.33%)
Volume$35.18K
Capitalization1.82B
APYX vs INMD Comparison Chart in %
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. INMD commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and INMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (APYX: $2.28 vs. INMD: $15.23)
Brand notoriety: APYX and INMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APYX: 39% vs. INMD: 83%
Market capitalization -- APYX: $47.46M vs. INMD: $1.82B
APYX [@Medical Specialties] is valued at $47.46M. INMD’s [@Medical Specialties] market capitalization is $1.82B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileINMD’s FA Score has 0 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • INMD’s FA Score: 0 green, 5 red.
According to our system of comparison, INMD is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 4 TA indicator(s) are bullish while INMD’s TA Score has 5 bullish TA indicator(s).

  • APYX’s TA Score: 4 bullish, 4 bearish.
  • INMD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both APYX and INMD are a good buy in the short-term.

Price Growth

APYX (@Medical Specialties) experienced а +1.79% price change this week, while INMD (@Medical Specialties) price change was +0.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was +0.94%.

Reported Earning Dates

APYX is expected to report earnings on Nov 06, 2025.

INMD is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMD($1.82B) has a higher market cap than APYX($47.5M). APYX YTD gains are higher at: 36.709 vs. INMD (-9.102). INMD has higher annual earnings (EBITDA): 196M vs. APYX (-18.11M). INMD has more cash in the bank: 742M vs. APYX (43.7M). INMD has less debt than APYX: INMD (9.02M) vs APYX (38.5M). INMD has higher revenues than APYX: INMD (492M) vs APYX (52.3M).
APYXINMDAPYX / INMD
Capitalization47.5M1.82B3%
EBITDA-18.11M196M-9%
Gain YTD36.709-9.102-403%
P/E RatioN/A9.13-
Revenue52.3M492M11%
Total Cash43.7M742M6%
Total Debt38.5M9.02M427%
FUNDAMENTALS RATINGS
APYX vs INMD: Fundamental Ratings
APYX
INMD
OUTLOOK RATING
1..100
736
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9840
PRICE GROWTH RATING
1..100
3557
P/E GROWTH RATING
1..100
10074
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (57) in the Medical Specialties industry is in the same range as INMD (64) in the null industry. This means that APYX’s stock grew similarly to INMD’s over the last 12 months.

INMD's Profit vs Risk Rating (98) in the null industry is in the same range as APYX (100) in the Medical Specialties industry. This means that INMD’s stock grew similarly to APYX’s over the last 12 months.

INMD's SMR Rating (40) in the null industry is somewhat better than the same rating for APYX (98) in the Medical Specialties industry. This means that INMD’s stock grew somewhat faster than APYX’s over the last 12 months.

APYX's Price Growth Rating (35) in the Medical Specialties industry is in the same range as INMD (57) in the null industry. This means that APYX’s stock grew similarly to INMD’s over the last 12 months.

INMD's P/E Growth Rating (74) in the null industry is in the same range as APYX (100) in the Medical Specialties industry. This means that INMD’s stock grew similarly to APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXINMD
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJIQX14.94N/A
N/A
PGIM Jennison Global Equity Income R6
JHAAX10.27N/A
N/A
JHancock Multi-Asset Absolute Return A
UBVRX81.16N/A
N/A
Undiscovered Managers Behavioral Val R2
HDCEX9.87N/A
N/A
Rational Equity Armor Fund C
CRLSX11.02N/A
N/A
Catholic Rspnsbl Invstmnts Intl Eq Ins

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-5.26%
CORBF - APYX
36%
Loosely correlated
+36.24%
MKEAF - APYX
33%
Loosely correlated
N/A
IQV - APYX
27%
Poorly correlated
+2.17%
ESTA - APYX
26%
Poorly correlated
+2.02%
RDNT - APYX
25%
Poorly correlated
-0.21%
More

INMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMD has been loosely correlated with CRL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMD
1D Price
Change %
INMD100%
-0.33%
CRL - INMD
45%
Loosely correlated
+2.95%
IDXX - INMD
44%
Loosely correlated
+0.08%
RVTY - INMD
44%
Loosely correlated
+2.27%
MTD - INMD
43%
Loosely correlated
+1.44%
TMCI - INMD
43%
Loosely correlated
-0.16%
More